Esmolol in septic shock: old pathophysiological concepts, an old drug, perhaps a new hemodynamic strategy in the right patient
- PMID: 28066583
- PMCID: PMC5179389
- DOI: 10.21037/jtd.2016.11.111
Esmolol in septic shock: old pathophysiological concepts, an old drug, perhaps a new hemodynamic strategy in the right patient
Conflict of interest statement
Salvatore Mario Romano has a patent “Method and apparatus for measuring cardiac flow output” (USA Patent Number 6758822). The authors have no conflicts of interest to declare.
Comment on
-
Beta-blockers in septic shock: a magnifying glass on the relation heart vessel.J Thorac Dis. 2016 Aug;8(8):E802-4. doi: 10.21037/jtd.2016.07.12. J Thorac Dis. 2016. PMID: 27619336 Free PMC article. No abstract available.
-
Heart rate reduction may be a major determinant of vascular tone in esmolol-treated septic shock patients-although still remains to be confirmed!J Thorac Dis. 2016 Aug;8(8):E829-32. doi: 10.21037/jtd.2016.07.66. J Thorac Dis. 2016. PMID: 27619799 Free PMC article. No abstract available.
-
Ventriculo-arterial coupling: the comeback?J Thorac Dis. 2016 Sep;8(9):2287-2289. doi: 10.21037/jtd.2016.08.34. J Thorac Dis. 2016. PMID: 27746956 Free PMC article. No abstract available.
-
Beta-blockers in patients with septic shock: plenty of promise, but no hard evidence yet.J Thorac Dis. 2016 Sep;8(9):E1041-E1043. doi: 10.21037/jtd.2016.08.52. J Thorac Dis. 2016. PMID: 27747057 Free PMC article. No abstract available.
References
-
- Masson S, Caironi P, Fanizza C, et al. Sequential N-Terminal Pro-B-Type Natriuretic Peptide and High-Sensitivity Cardiac Troponin Measurements During Albumin Replacement in Patients With Severe Sepsis or Septic Shock. Crit Care Med 2016;44:707-16. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources